Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,908,511 5.300% | 22,495 (+1.19%) | Filing History |
| 2025-01-30 9:58 pm Purchase | 2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | The Vanguard Group | 1,673,587 4.640% | 1,673,587 (New Position) | Filing History |
| 2024-12-23 8:08 pm Purchase | 2024-12-17 | 13G | Inovio Pharmaceuticals, Inc. INO | Stonepine Capital Management LLC | 1,916,666 5.200% | 1,916,666 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,886,016 7.300% | 0 (Unchanged) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,886,016 7.300% | 1,886,016 (New Position) | Filing History |
| 2024-04-26 4:01 pm Purchase | 2024-04-16 | 13G | Inovio Pharmaceuticals, Inc. INO | Deep Track Capital, LP | 2,593,822 9.990% | 2,593,822 (New Position) | Filing History |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | Inovio Pharmaceuticals, Inc. INO | The Vanguard Group | 19,766,042 7.240% | 18,345,834 (+1291.77%) | Filing History |
| 2024-01-22 10:20 am Sale | 2023-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | STATE STREET CORP STT | 72,587 0.320% | -533 (-0.73%) | Filing History |
| 2023-07-10 2:07 pm Sale | 2023-06-30 | 13G | Inovio Pharmaceuticals, Inc. INO | STATE STREET CORP STT | 73,121 0.330% | -2,549,575 (-97.21%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 507,219 2.300% | -1,433,125 (-73.86%) | Filing History |
| 2023-02-09 3:11 pm Purchase | 2022-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | STATE STREET CORP STT | 2,622,696 12.610% | 683,702 (+35.26%) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Inovio Pharmaceuticals, Inc. INO | The Vanguard Group | 1,420,208 6.830% | 500,266 (+54.38%) | Filing History |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,940,343 9.300% | 419,934 (+27.62%) | Filing History |
| 2022-04-11 2:07 pm Purchase | 2022-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO | STATE STREET CORP STT | 1,938,994 10.490% | 830,625 (+74.94%) | Filing History |
| 2022-02-11 11:41 am Purchase | 2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | STATE STREET CORP STT | 1,108,369 6.320% | 367,156 (+49.53%) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | The Vanguard Group | 919,943 5.250% | 154,473 (+20.18%) | Filing History |
| 2022-02-01 5:08 pm Purchase | 2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,520,410 8.700% | 333,498 (+28.10%) | Filing History |
| 2021-02-11 4:03 pm Sale | 2020-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | Nikko Asset Management Americas Inc. | 0 0.000% | -420,634 (Position Closed) | Filing History |
| 2021-02-11 2:42 pm Sale | 2021-02-11 | 13G | Inovio Pharmaceuticals, Inc. INO | WASATCH ADVISORS LP | 328,252 2.300% | -295,317 (-47.36%) | Filing History |
| 2021-02-10 11:04 am Purchase | 2020-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | The Vanguard Group | 765,470 5.420% | 344,437 (+81.81%) | Filing History |